Clinical Efficacy of Ceftazidime in Treating 86 Cases with Puerperal Infection
Yin Bao-min
Abstract
Yin Bao-min
Abstract
Objective: To evaluate the efficacy and safety of ceftazidime in the treatment of puerperal infection. Methods: 86 patients were treated with ceftazidime at 4 g/d,bid,iv drip. Duration of treatment was 7-10 days. The efficacy and bacteriology were observed. Results: Clinical cure rate was 89.6% and effective rate was 97.7%. The bacterial clearance rate was 91.1%. The adverse reactions were mild and less-frequent. Conclusion: Ceftazidime for treatment of puerperal infection is effective and safe.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To evaluate the efficacy and safety of ceftazidime in the treatment of puerperal infection. Methods: 86 patients were treated with ceftazidime at 4 g/d,bid,iv drip. Duration of treatment was 7-10 days. The efficacy and bacteriology were observed. Results: Clinical cure rate was 89.6% and effective rate was 97.7%. The bacterial clearance rate was 91.1%. The adverse reactions were mild and less-frequent. Conclusion: Ceftazidime for treatment of puerperal infection is effective and safe.
Key concepts: Ceftazidime, Medicine, Clinical efficacy, Cure rate, Puerperal Infection, Bacteriology, Adverse effect, Internal medicine